Inzy stock forecast.

Analyst Forecast According to 4 analysts, the average rating for INZY stock is "Strong Buy." The 12-month stock price forecast is $15.0, which is an increase of 306.50% from the latest price.APP | Complete Applovin Corp. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. Skip to main content. S&P 500 …We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.

See Inozyme Pharma, Inc. (INZY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Their INZY share price targets range from $6.00 to $23.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts price targets for INZY or view top-rated stocks among Wall Street analysts.

Find the latest Moleculin Biotech, Inc. (MBRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 154.20M. -37.63%. Get the latest Incyte Corporation (INCY) real-time ... Find the latest Eos Energy Enterprises, Inc. (EOSE) stock quote, history, news and other vital information to help you with your stock trading and investing.Is Inozyme Pharma Stock Undervalued? The current Inozyme Pharma share price is $3.85. The Score for INZY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Aug 9, 2023 · For the current quarter, INZY is expected to report an EPS forecast of -$0.45. In terms of annual financials, INZY reported an annual revenue of $0.00 for the last year and an annual profit of -$67.1 million. INZY Stock Shows Promising Performance on August 9, 2023: Optimistic Price Forecasts and Unanimous Buy Rating. INZY stock, belonging to ...

Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Incyte Corp have a median target of 71.00, with a high estimate of 93.00 and a low estimate of 58.00. The median ...

BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics …

Incyte stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Incyte cost in 2021-2025?As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.INZY has a market cap of $257mn and a cash balance of $148mn. R&D expenses were $47.8 million for the year ended December 31, 2022, while G&A expenses were $20.8 million. At that rate, they have …On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average rating of …View today's Inozyme Pharma Inc stock price and latest INZY news and analysis. Create real-time notifications to follow any changes in the live stock price.Overview Inozyme Pharma Inc. U.S.: Nasdaq Add to WatchlistAccording to our current INZY stock forecast, the value of Inozyme Pharma shares will rise by 7.27% and reach $ 3.50 per share by November 24, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).

Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing.Price Performance Review of INZY. On Monday, Inozyme Pharma Inc [NASDAQ:INZY] saw its stock fall -5.97% to $2.99. On the same session, the stock had its day’s lowest price of $2.97, but rose to a high of $3.22. Over the last five days, the stock has gained 2.05%. Inozyme Pharma Inc shares have risen nearly 184.76% since the year began.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $15.00 with a high price target of $23.00 and a low price target of $6.00. Learn more on INZY's analyst rating history.According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy. Analyst Consensus: Strong Buy. Target Low Average Median High; Price: $116: $170.76: …Complete Inozyme Pharma Inc. stock information by Barron's. View real-time INZY stock price and news, along with industry-best analysis.

Source Headline; Inozyme Pharma's (INZY) "Buy" Rating Reaffirmed at Needham & Company LLC americanbankingnews.com - November 12 at 4:20 AM: FY2023 Earnings Forecast for Inozyme Pharma, Inc. Issued By HC Wainwright (NASDAQ:INZY) americanbankingnews.com - November 11 at 2:16 AM Inozyme Pharma, Inc. …Which executives are buying and selling shares of Inozyme Pharma stock? View the latest INZY insider trading activity at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. Closing prices for crude oil, gold and other commodities. ... Advanced Stock Screeners and Research Tools.

What this means: Inozyme Pharma Inc (INZY) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. 566.33%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -1.63M. -77.72%. Get the latest Immix Biopharma Inc (IMMX ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...Inozyme Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction. ... INZY Related stocks. Symbol 3M %Chg ; INZY -36.16% : Inozyme Pharma Inc: AMGN +3 ...Nov 24, 2023 · Stock Price Forecast. According to 16 stock analysts, the average 12-month stock price forecast for Incyte stock is $79.25, which predicts an increase of 47.47%. The lowest target is $60 and the highest is $100. On average, analysts rate Incyte stock as a buy. Join Seeking Alpha, the largest investing community in the world. Get stock market news and analysis, investing ideas, earnings calls, charts and portfolio analysis tools.What is Incyte's Market Cap? ( NASDAQ: INCY) Incyte 's market cap is $11.75B, as of Nov 12, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Incyte 's market cap is calculated by multiplying INCY 's current stock price of $52.44 by INCY 's total outstanding shares of …Find the latest Tantech Holdings Ltd (TANH) stock quote, history, news and other vital information to help you with your stock trading and investing.

Inozyme Pharma, Inc. (INZY) stock forecast and price target. Find the latest Inozyme Pharma, Inc. INZY analyst stock forecast, price target, and recommendation trends with in-depth analysis from ...

Get The Latest BRID Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Bread Frozen Dough Market Analysis by Top Companies and Forecast 2031. See More Headlines .

The predictions for the future INCY stock price range from a low of $63.00 to a high of $136.00, highlighting the variability of market expectations for INCY ...You can view all of the due diligence checks on INZY's stock page. How is INZY stock valued? Investors. use many financial metrics, analyses, models, and charts to gauge INZY's intrinsic value.Using relative valuations . measures:INZY; may be undervalued based on its P/B ratio of 1.42x, relative to Biotechnology industry P/B ratio of . 5.35xView the latest Inozyme Pharma Inc. (INZY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Forecast . Price target. 21.00 0.00 0.00%. The 6 analysts offering 1 year price forecasts for INZY have a max estimate of — and a min estimate of —. Analyst rating. Based on 7 analysts giving stock ratings to INZY in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreINZY Signals & Forecast The Inozyme Pharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.Find the latest Fangdd Network Group Ltd. (DUO) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Inozyme Pharma Inc have a median target of 16.00, with a high estimate of 40.00 and a low estimate of 15.00. The median ... Incyte Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system. Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting ...INZY Stock 12 Months Forecast. $16.00. (315.58% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Inozyme Pharma in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 315.58% change from the last price of $3.85. Find the latest Inozyme Pharma, Inc. (INZY) stock quote, history, news and other vital information to help you with your stock trading and investing.Inozyme Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction. ... INZY Related stocks. Symbol 3M %Chg ; INZY -36.16% : Inozyme Pharma Inc: AMGN +3 ...

The Walt Disney Company (NYSE:DIS) posted its earnings results on Wednesday, November, 8th. The entertainment giant reported $0.82 earnings per share for the quarter, beating analysts' consensus estimates of $0.67 by $0.15. The entertainment giant earned $21.24 billion during the quarter, compared to analysts' expectations of …Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...Forecast . Price target. 21.00 0.00 0.00%. The 6 analysts offering 1 year price forecasts for INZY have a max estimate of — and a min estimate of —. Analyst rating. Based on 7 analysts giving stock ratings to INZY in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreFind the latest MAIA Biotechnology, Inc. (MAIA) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. ladder t billsforex vs stockets stockblack line stock Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing. birch gold group pros and conslist of preferred stocks Stock Price Forecast. According to 16 stock analysts, the average 12-month stock price forecast for Incyte stock is $79.25, which predicts an increase of 47.47%. The lowest target is $60 and the highest is $100. On average, analysts rate Incyte stock as a buy. sales enablement software market size On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average ...Get The Latest BRID Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Bread Frozen Dough Market Analysis by Top Companies and Forecast 2031. See More Headlines .Aug 29, 2023 · Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance